Solasta Ventures
Home Approach Portfolio
News Team Hatchery Contact
HomeApproachPortfolio
Solasta Ventures
NewsTeamHatcheryContact
Xilio Therapeutics Announces Pricing of Initial Public Offering
Nia JulianOctober 25, 2021
Facebook0 Twitter Pinterest0 0 Likes
Previous

Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™

Nia JulianOctober 27, 2021
Next

Takeda taps Selecta for $1.1B gene therapy research pact

Nia JulianOctober 6, 2021

© 2020 Solasta Ventures. All Rights Reserved.